Breaking News Bar

Business News and Information

Pfizer guts it out in obesity, diabetes deal with Second Genome

Pfizer Inc., with the help of South San Francisco’s Second Genome, wants to peer into the gut to discover how the cast of bacterial characters there plays a role in obesity and diabetes...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear